BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30638838)

  • 1. Hypothermic perfusion of donor heart with a preservation solution supplemented by mesenchymal stem cells.
    Korkmaz-Icöz S; Li S; Hüttner R; Ruppert M; Radovits T; Loganathan S; Sayour AA; Brlecic P; Lasitschka F; Karck M; Szabó G
    J Heart Lung Transplant; 2019 Mar; 38(3):315-326. PubMed ID: 30638838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-dead donor heart conservation with a preservation solution supplemented by a conditioned medium from mesenchymal stem cells improves graft contractility after transplantation.
    Korkmaz-Icöz S; Li K; Loganathan S; Ding Q; Ruppert M; Radovits T; Brlecic P; Sayour AA; Karck M; Szabó G
    Am J Transplant; 2020 Oct; 20(10):2847-2856. PubMed ID: 32162462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell secretions improve donor heart function following ex vivo cold storage.
    Wang M; Yan L; Li Q; Yang Y; Turrentine M; March K; Wang IW
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):e277-e292. PubMed ID: 32981709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplementing preservation solution with mitochondria-targeted H
    Zhu C; Su Y; Juriasingani S; Zheng H; Veramkovich V; Jiang J; Sener A; Whiteman M; Lacefield J; Nagpal D; Alotaibi F; Liu K; Zheng X
    Am J Transplant; 2019 Nov; 19(11):3139-3148. PubMed ID: 31338943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor heart preservation with hypoxic-conditioned medium-derived from bone marrow mesenchymal stem cells improves cardiac function in a heart transplantation model.
    Zhou P; Liu H; Liu X; Ling X; Xiao Z; Zhu P; Zhu Y; Lu J; Zheng S
    Stem Cell Res Ther; 2021 Jan; 12(1):56. PubMed ID: 33435991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditioned Medium from Mesenchymal Stem Cells Alleviates Endothelial Dysfunction of Vascular Grafts Submitted to Ischemia/Reperfusion Injury in 15-Month-Old Rats.
    Korkmaz-Icöz S; Sun X; Li S; Brlecic P; Loganathan S; Ruppert M; Sayour AA; Radovits T; Karck M; Szabó G
    Cells; 2021 May; 10(5):. PubMed ID: 34067928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-ischemic Heart Preservation via Hypothermic Cardioplegic Perfusion Induces Immunodepletion of Donor Hearts Resulting in Diminished Graft Infiltration Following Transplantation.
    Critchley WR; Stone JP; Liao Q; Qin G; Risnes I; Trafford A; Scott H; Sjöberg T; Steen S; Fildes JE
    Front Immunol; 2020; 11():1621. PubMed ID: 32849549
    [No Abstract]   [Full Text] [Related]  

  • 8. Short- and long-term effects of brain death on post-transplant graft function in a rodent model.
    Li S; Korkmaz S; Loganathan S; Radovits T; Hegedűs P; Karck M; Szabó G
    Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):379-86. PubMed ID: 25505342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved heart function from older donors using pharmacologic conditioning strategies.
    Kumarasinghe G; Gao L; Hicks M; Villanueva J; Doyle A; Rao P; Ru Qiu M; Jabbour A; Iyer A; Chew HC; Hayward CS; Macdonald P
    J Heart Lung Transplant; 2016 May; 35(5):636-46. PubMed ID: 26899770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell-derived conditioned medium protects vascular grafts of brain-dead rats against in vitro ischemia/reperfusion injury.
    Korkmaz-Icöz S; Zhou P; Guo Y; Loganathan S; Brlecic P; Radovits T; Sayour AA; Ruppert M; Veres G; Karck M; Szabó G
    Stem Cell Res Ther; 2021 Feb; 12(1):144. PubMed ID: 33627181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor pretreatment with adenosine monophosphate-activated protein kinase activator protects cardiac grafts from cold ischaemia/reperfusion injury.
    Yang C; Xu H; Cai L; Du X; Jiang Y; Zhang Y; Zhou H; Chen ZK
    Eur J Cardiothorac Surg; 2016 May; 49(5):1354-60. PubMed ID: 26609046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Custodiol vs warm blood cardioplegia and conditioning of donor hearts during transportation with the organ care system.
    Kaliyev R; Lesbekov T; Bekbossynov S; Bekbossynova M; Nurmykhametova Z; Novikova S; Smagulov N; Medressova A; Faizov L; Ashyrov Z; la Fleur P; Samalavicius R; Pya Y
    J Card Surg; 2019 Oct; 34(10):969-975. PubMed ID: 31332833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservation solution Custodiol containing human alpha-1-antitrypsin improves graft recovery after prolonged cold ischemic storage in a rat model of heart transplantation.
    Korkmaz-Icöz S; Abulizi S; Li K; Korkmaz B; Georgevici AI; Sayour AA; Loganathan S; Canoglu H; Karck M; Szabó G
    Front Immunol; 2023; 14():1155343. PubMed ID: 37426668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous perfusion of donor hearts with oxygenated blood cardioplegia improves graft function.
    Zhang F; Mo A; Wen Z; Zhou Y; Liang S; Lin H
    Transpl Int; 2010 Nov; 23(11):1164-70. PubMed ID: 20500562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for myocardial protection: transfection of donor hearts with heat shock protein 70 gene protects cardiac function against ischemia-reperfusion injury.
    Jayakumar J; Suzuki K; Khan M; Smolenski RT; Farrell A; Latif N; Raisky O; Abunasra H; Sammut IA; Murtuza B; Amrani M; Yacoub MH
    Circulation; 2000 Nov; 102(19 Suppl 3):III302-6. PubMed ID: 11082405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marginal donors: can older donor hearts tolerate prolonged cold ischemic storage?
    Korkmaz S; Bährle-Szabó S; Loganathan S; Li S; Karck M; Szabó G
    Aging Clin Exp Res; 2013 Oct; 25(5):597-600. PubMed ID: 23949977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twelve-Hour Hypothermic Machine Perfusion for Donor Heart Preservation Leads to Improved Ultrastructural Characteristics Compared to Conventional Cold Storage.
    Michel SG; La Muraglia GM; Madariaga ML; Titus JS; Selig MK; Farkash EA; Allan JS; Anderson LM; Madsen JC
    Ann Transplant; 2015 Aug; 20():461-8. PubMed ID: 26259549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor blood perfusion improves myocardial recovery after heart transplantation.
    Rao V; Feindel CM; Weisel RD; Boylen P; Cohen G
    J Heart Lung Transplant; 1997 Jun; 16(6):667-73. PubMed ID: 9229297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supplemental hydrogen sulphide protects transplant kidney function and prolongs recipient survival after prolonged cold ischaemia-reperfusion injury by mitigating renal graft apoptosis and inflammation.
    Lobb I; Mok A; Lan Z; Liu W; Garcia B; Sener A
    BJU Int; 2012 Dec; 110(11 Pt C):E1187-95. PubMed ID: 23157304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow-targeted pediatric ex vivo heart perfusion in donation after circulatory death: A porcine model.
    Kobayashi J; Luo S; Akazawa Y; Parker M; Wang J; Chiasson D; Friedberg MK; Haller C; Honjo O
    J Heart Lung Transplant; 2020 Mar; 39(3):267-277. PubMed ID: 31892427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.